Changes in the Crohn’s Disease Activity Index and Safety of Administering Saccharomyces Boulardii in Patients with Crohn’s Disease in Clinical Remission: A Single Hospital-based Retrospective Cohort Study | Zendy

Gyu Man Oh | Zendy; Won Moon | Zendy; Kwang Il Seo | Zendy; Kyoungwon Jung | Zendy; Jae Hyun Kim | Zendy; Sung Eun Kim | Zendy; Moo In Park | Zendy; Seun Ja Park | Zendy

Open Access

Changes in the Crohn’s Disease Activity Index and Safety of Administering Saccharomyces Boulardii in Patients with Crohn’s Disease in Clinical Remission: A Single Hospital-based Retrospective Cohort Study

Author(s) -

Gyu Man Oh,

Won Moon,

Kwang Il Seo,

Kyoungwon Jung,

Jae Hyun Kim,

Sung Eun Kim,

Moo In Park,

Seun Ja Park

Publication year - 2020

Publication title -

korean journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.203

H-Index - 25

eISSN - 2233-6869

pISSN - 1598-9992

DOI - 10.4166/kjg.2020.115

Subject(s) - medicine , saccharomyces boulardii , gastroenterology , calprotectin , crohn's disease , retrospective cohort study , body mass index , inflammatory bowel disease , disease , probiotic , genetics , bacteria , biology

Crohn's disease (CD) is characterized by uncontrolled inflammation of the intestine. Saccharomyces boulardii ( S. boulardii ), a probiotic, stabilizes the intestinal wall. This study examined the changes in the CD activity index (CDAI) after taking S. boulardii in patients with CD in clinical remission.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research